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RNA-binding proteins(HDV) relies on human transcriptional machinery for its replication and
transcription. Although the involvement of RNA polymerase II in HDV RNA biosynthesis is established, the
contribution of additional polymerases remains uncertain. Here, we demonstrate the interaction of both RNA
polymerase I and III with HDV RNA, both in vitro and in human cells. Binding of these polymerases occurs
near the terminal stem-loop domains of both polarities of the HDV RNA genome. Based on interactions of
HDV RNA with numerous host polymerases, our results suggest a higher level of complexity of HDV biology
than previously envisioned.
© 2009 Elsevier Inc. All rights reserved.Introduction
The hepatitis delta virus (HDV) is composed of a single-stranded
circular RNA molecule of approximately 1700 nucleotides that folds
into a rod-like structure and contains a single open reading frame
(Taylor, 2006). Because HDV does not encode an RNA-dependent RNA
polymerase, it relies on host polymerase(s) for its replication and
transcription. It is acknowledged that RNA polymerase II (RNAP II) is
involved in HDV replication based on the sensitivity of the process to
α-amanitin, and on the post-transcriptional processing of the HDV
mRNA (i.e. HDAg mRNA) with a 5′ methylguanine cap and a poly(A)
tail (MacNaughton et al., 1991; Fu and Taylor, 1993; Gudima et al.,
1999; Lai, 2005; Taylor, 2006). Recently, we conﬁrmed the interaction
of RNAP II with HDV RNA both in vitro and in vivo and demonstrated
the binding of this polymerase to the terminal stem-loop domains of
both polarities of the HDV genome (Greco-Stewart et al., 2007). The
involvement of RNAP I in HDV biology has been suggested based on
the resistance of antigenomic RNA production to higher doses of α-
amanitin, on the co-localization of RNAP I with antigenomic HDV RNA,
on the interaction of HDAg-S with components of the RNAP I
transcription factor SL1, and on the inhibition of antigenomic RNA
synthesis in vitro by α-SL1 antibody (Modahl et al., 2000; Macnaugh-
ton et al., 2002; Li et al., 2006). However, no direct interaction
between RNAP I and HDV RNA has been reported, and a role for RNAP
III in HDV replication has never been investigated. In this study, wel rights reserved.report the association of both RNAP I and RNAP III components with
HDV RNA, both in vitro and in vivo. Our results indicate the recruitment
of the two RNAPs by both polarities of HDV RNA and the possible
involvement of the TATA-binding protein (TBP) in these processes. Our
data suggest a mechanism of HDV replication involving all three
human RNAPs.
Results
HDV RNA interacts with components of RNAP I and RNAP III in cells
replicating HDV
Because RNAPs must bind their templates to transcribe, we
investigated whether components of RNAP I and/or RNAP III associate
with the HDV RNA genome in cells replicating HDV RNA. To establish
these interactions, we took advantage of a ribonucleoprotein
immunoprecipitation assay (RIPA), which has been successfully used
to indicate HDAg, PSF, and RNAP II interaction with HDV RNA
(Niranjanakumari et al., 2002; Greco-Stewart et al., 2006, 2007).
HeLa cells were co-transfected with a dimeric HDV RNA genome and a
plasmid expressing HDAg-S. Four days post-transfection, the ribonu-
cleoproteins were cross-linked with formaldehyde and immunopre-
cipitated using antibodies against either TAF I p95/110 (TAF1) or RNAP
III polypeptide K (POLR3K). TAF1 is a component of the transcription
factor SL1 which directs the assembly of initiation complexes at RNAP
I promoters. POLR3K is one of the core subunits of RNAP III. Following
immunoprecipitation, the cross-links were reversed by heating the
samples and the recovered nucleic acids were subjected to RT-PCR
Fig. 1. Interaction of RNAP I and RNAP III components with HDV RNA in HeLa cells. HeLa
cells replicating HDV RNA were used for the preparation of cross-linked lysates for co-
immunoprecipitation using either α-TAF1 (A), α-POLR3K (B), α-IgG, or no antibody.
Experiments using non-cross-linked lysates are also presented. G and AG lanes contain
RT reactions performed using primers complementary to either genomic or anti-
genomic HDV RNA corresponding to the R199 region. HDVG and HDVAG RNA lanes are
controls using in vitro transcribed HDV RNA of genomic and antigenomic polarity,
respectively. Lanes M contain GelPilot Mid Range DNA ladder (Qiagen).
Fig. 2. Association of TAF1 and POLR3K with HDV-derived RNAs. (A) Co-immunopre-
cipitations of radiolabelled R199Gwith TAF1 in HeLa NE. 50-fold excess non-radioactive
R199G, poly(A) RNA, or P11.60 (Pelchat and Perreault, 2004) were used as competitors.
(B) Compilation of the interaction of various HDV-derived RNAs with both TAF1 and
POLR3K.
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the R199 region (see Fig. 2B) (Greco-Stewart et al., 2007).
HDV RNA associated with both TAF1 and POLR3K in cross-linked
HeLa cells. The interactions were speciﬁc since HDV RNA failed to co-
immunoprecipitate in the absence of formaldehyde treatment, with-
out antibody, or in the presence of a non-related antibody (i.e. α-IgG;
Fig. 1). In addition, the primers used in the RT reactions allowed
differentiation between the polarities of HDV RNA, as demonstrated
when in vitro transcribed HDV RNAs were subjected to RT-PCR (Fig. 1,
HDVG RNA and HDVAG RNA lanes) (Greco-Stewart et al., 2007). Since
both polarities of HDV RNA were recovered when the cross-linked
samples were immunoprecipitated with these antibodies, we con-
clude that both TAF1 and POLR3K associate with both polarities of
HDV RNA within HeLa cells.
RNAP I and RNAP III components bind close to the terminal stem-loop
domains of HDV
To determine the regions of the HDV genome to which subunits of
RNAP I and RNAP III bind, various portions of the HDV genome were
transcribed in vitro, radiolabelled, and subjected to co-immunopre-
cipitation using α-TAF1 and α-POLR3K antibodies (Fig. 2). Fig. 2A
shows a representative experiment using a segment of the right
terminal stem-loop domain of genomic polarity (i.e. R199G). R199G
associated with TAF1 in the presence of HeLa NE proteins. In the
absence of antibody or in the presence of a non-related antibody (i.e.
α-IgG), R199G failed to associate with TAF1. TAF1 binding was not
hindered by the addition of a 50-fold excess of either P11.60 or poly(A)
RNA, although a 50-fold excess of unlabelled homologous competitor
prevented association. P11.60 is a small RNA species that folds into a
hairpin (Pelchat and Perreault, 2004), thus providing an excellent
competitive RNA to test for non-speciﬁc afﬁnity of the proteins to
double-stranded RNA or stem-loop secondary structures.
Co-immunoprecipitations of the terminal stem-loop domains (i.e.
R199G, R199AG, L213G, and L213AG) and the central regions (i.e.
CENTRG and CENTRAG) of both polarities of HDV RNAwere performedusing both antibodies.We observed interaction of TAF1 and POLR3K to
fragments containing the terminal stem-loop domains of the HDV
genome of both polarities (Fig. 2B) in a manner similar to what was
observed for RNAP II interaction (Greco-Stewart et al., 2007). These
data suggest that not only RNAP II, but also RNAP I and RNAP III, might
be involved in HDV biology through speciﬁc association with the
extremities of both polarities of the HDV RNA genome.
To further reﬁne the regions interacting with both RNAP I and
RNAP III and to determine if the RNA features bound by those RNAPs
are identical to those used by RNAP II, two small HDV-derived
transcripts reported to be able to associate with RNAP II were
synthesized and were used in the co-immunoprecipitation reactions
(Greco-Stewart et al., 2007). Speciﬁcally, R38G and L48AG, which
correspond to 38 and 48 nt RNAs located at the tip of the right
genomic and the left antigenomic hairpin domains, respectively, were
tested. These two small RNA molecules were not able to co-
immunoprecipitate using either α-TAF1 or α-POLR3K antibodies
(Fig. 2B), suggesting either that those proteins do not bind to the tip of
the rod-like structure of HDV RNA or that additional features present
on the larger RNA species are required.
RNAP I and RNAP III binding to HDV RNA is independent and involves the
TATA-binding protein
The binding of the three RNAPs to the same regions of HDV RNA
suggests a common mechanism of RNA recognition, which might
involve a shared subunit. Since TBP is common to three RNAPs during
DNA promoter recognition (Goodrich and Tjian,1994) and this protein
was suggested to be involved in HDV RNA promoter recognition by
RNAP II (Abrahem and Pelchat, 2008), we speculated that TBP might
14 Rapid Communicationbe present during the binding of HDV RNA to both RNAP I and RNAP III.
RIPA was initially performed to determine the association of TBP with
HDV RNA in HeLa cells. As shown in Fig. 3A, TBP associated with both
polarities of HDV RNA in vivo. HDV RNA binding to TBP was speciﬁc
since the RIPAwas only successful in cross-linked HeLa cells and failed
in the absence of α-TBP antibody or in the presence of a non-related
antibody. However, this assay did not discriminate the polymerase
involved.
To verify the presence of TBP in both RNAP I and RNAP III
complexes independently of one another and of RNAP II, we
performed RNA afﬁnity chromatography followed by immunopreci-
pitation and Western analysis. For this purpose, we selected R199G,
which binds to all three RNAPs (Fig. 2B and Greco-Stewart et al., 2007),
and added an RNA tag with an afﬁnity for streptavidin (Srisawat and
Engelke, 2002). We used a tagged P11.60 as a negative control since
P11.60 does not bind human RNAPs (this work and Greco-Stewart et
al., 2007). The tagged RNAs were immobilized on streptavidin-agarose
beads and incubated with HeLa NE. Following washes, the RNP
complexes were eluted by competition with molecular excess of d-
biotin, immunoprecipitated with either α-TAF1 or α-POLR3K anti-
body, and the presence of the tagged RNAs was conﬁrmed by PAGE
(data not shown). The samples were then subjected to SDS-PAGE, and
Western blotting was performed to determine the composition of
these complexes using speciﬁc antibodies.
TAF1 but not POLR3K was detected in complexes immunopreci-
pitated using the α-TAF1 antibody (Fig. 3B). Conversely, complexes
immunoprecipitated using the α-POLR3K antibody contained POLR3K
but not TAF1. However, TBP was common to both complexes. Neither
proteinwas detected when S1-R199G was substituted with S1-P11.60,
indicating the speciﬁcity of these protein–RNA interactions (Fig. 3B).
To further demonstrate that RNAP II was not involved in the formation
of these complexes, the TAF1 and POLR3K complexes were each
probed with an antibody against RNAP II carboxyl-terminal domain
(Fig. 3B). RNAP II was not present in either of these complexes,
indicating that HDV RNA binding to both TAF1 and POLR3K isFig. 3. Presence of TBP in both RNAP I and RNAP III complexes on HDV RNA. (A)
Interaction of TBP with HDV RNA within HeLa cells, as described in Fig. 1 using α-TBP.
(B) Mutual exclusivity of RNAP complexes and the involvement of TBP. S1-R199G and
S1-P11.60 RNA were immobilized on streptavidin-agarose beads and incubated with
HeLa NE. Following washes, the RNP complexes were eluted by competition with a
molecular excess of d-biotin, and immunoprecipitated with eitherα-TAF1 orα-POLR3K
antibodies. The proteins were detected using speciﬁc antibodies.independent of RNAP II binding. These results demonstrate the
binding of TAF1 and POLR3K complexes to HDV RNA, either
independently or through a common subunit, and suggest the
involvement of TBP in both RNAP I and RNAP III binding.
Discussion
Using antibodies directed against components of both RNAP I and
RNAP III, we have further implicated RNAP I in HDV replication and
strongly suggested a role for RNAP III in this process. Combined with
the established role of RNAP II, the association of both RNAP I and
RNAP III with HDV RNA suggests the involvement of the three human
RNAPs in HDV biology. Interestingly, the three RNAPs bind near or at
the terminal stem-loop domains of HDV (this work and Greco-Stewart
et al., 2007). TBP is common to the three RNAPs: it is found in the SL1
complex of RNAP I, the TFIID complex of RNAP II, and the TFIIIB
complex of RNAP III, as well as the SNAPc complex used in
transcription of snRNAs by both RNAPs II and III (Goodrich and
Tjian, 1994). TBP can recognize both TATA and TATA-less promoters
dependent on accessory transcription factors, and its afﬁnity for DNA
templates is mediated by electrostatic interactionswith the phosphate
backbone (Bewley et al., 1998), which could account for its ability to
bind HDV RNA despite the absence of known DNA promoter features.
Because TBP was found in the RNAP complexes, it is tempting to
suggest that this shared polymerase subunit might mediate binding of
all three RNAPs to an HDV template. In addition, we recently reported
that TBP binding occurs at the tip of the rod-like structure of HDV (i.e.
binding sites are within R38G and L48AG; Abrahem and Pelchat,
2008). Because additional features present on the larger RNA species
might be required for both RNAP I and RNAP III association, it is likely
that accessory host factors might bind to these features and provide a
link between the RNAPs and the HDV-derived RNA promoters at the
initiation phase of transcription.
RNAP I was reported to be implicated in the synthesis of
antigenomic, but not genomic HDV RNA (Modahl et al., 2000;
Macnaughton et al., 2002; Li et al., 2006). In addition, a role for
RNAP III in HDV replication has never been reported. It is therefore
possible that some of the associations observed in this studymight not
lead to transcription initiation. Because there is currently no suitable
assay to directly study the transcription of RNAPs on HDV RNA
templates, the roles of these RNAPs in the HDV life cycle will be
difﬁcult to address. The development of a sensitive and reproducible
transcription system using HDV RNAs will be crucial to allow a
straightforward testing of the relevance of our ﬁndings. Nevertheless,
the three human RNAPs are capable of independent binding to the
terminal stem-loop domains of HDV and each RNAP complex contains
TBP. Taken together, this study provides the foundation to further
investigate HDV biology by suggesting a role for the three human
RNAPs, where each polymerase complex might have a speciﬁc
function during HDV replication and transcription.
Materials and methods
RNA synthesis
HDV-derived RNAs and P11.60 were synthesized by run-off
transcription using T7 RNA polymerase, as previously described
(Pelchat and Perreault, 2004; Greco-Stewart et al., 2007). When
needed, S1 aptamer was encoded in one of the primers to generate a
streptavidin tag at the 3′ end of the RNAs (Srisawat and Engelke,
2002).
Ribonucleoprotein immunoprecipitation assay (RIPA)
HeLa cells were transfected with 6 μg of pCDNA3-AgS and 10 μg of
dimeric HDV genomic RNA (Greco-Stewart et al., 2007). ∼106 cells
15Rapid Communicationwere treated with 1% formaldehyde, disrupted by sonication, and co-
immunoprecipitated with the Protein-G Immunoprecipitation Kit
(Sigma-Aldrich) using α-TAF1 (Santa Cruz), α-POLR3K (U.S. Biologi-
cals), α-TBP (Upstate), or mouse α-IgG (Sigma-Aldrich) antibodies in
RIPA buffer (50 mM Tris–HCl, pH 7.5, 1% Nonidet P-40 (NP-40), 0.5%
sodium deoxycholate, 0.05% SDS, 1 mM EDTA, 150 mM NaCl), as
previously described (Niranjanakumari et al., 2002; Greco-Stewart et
al., 2007). Samples were then eluted, treated with DNAse I, phenol/
chloroform extracted, ethanol precipitated, and reverse transcribed
using strand-speciﬁc primers (Greco-Stewart et al., 2007). Samples
were ampliﬁed by 35 cycles of PCR using the same primers. Products
were resolved on 2% agarose gels and visualized by SYBR green
staining. These assays were performed at least twice.
Co-immunoprecipitation analysis
The protein-G Immunoprecipitation Kit was used with ∼50 μg
of HeLa Nuclear Extract (NE; Promega), 5 μg of antibody, and
∼1 pmol of 5′-end radiolabelled RNA, as previously described
(Greco-Stewart et al., 2007). Competitors included 50-fold molar
excess of poly(A) RNA, P11.60, or unlabelled homologous RNA.
Samples were incubated for 16 h at 4 °C with agitation, washed
ﬁve times with RIPA buffer, and eluted with acrylamide loading dye
(Sambrook et al., 1989). RNAs were separated on denaturing
polyacrylamide gels (PAGE) and results visualized by phosphor-
imager scanning (Molecular Dynamics). These assays were performed
at least twice.
Afﬁnity puriﬁcation of ribonucleoprotein complexes
30 μl of pre-washed streptavidin agarose beads (Invitrogen) was
incubated with ∼200 μg of HeLa NE and 1 nmol of RNA (either S1-
R199G or S1-P11.60) in 50 mM HEPES (pH 7.4), 10 mM MgCl2, and
100 mM NaCl for 1 h at 4 °C, followed by a 3 hour wash in the same
buffer. Samples were eluted by the addition of 5 mM d-biotin
(Sigma-Aldrich) and then subjected to co-immunoprecipitation, as
above. SDS loading dye was added to elute the samples, which were
subjected to SDS-PAGE and Western blotting using the One Hour
Complete Western Kit (Genscript) using the antibodies described
above, or one directed against RNAP II carboxyl-terminal domain
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